0.00Open0.14Pre Close0 Volume22 Open Interest2.00Strike Price0.00Turnover311.87%IV100.00%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.14Extrinsic Value100Contract SizeAmericanOptions Type0.3536Delta0.4333Gamma7.64Leverage Ratio-0.0067Theta0.0002Rho2.70Eff Leverage0.0010Vega
CytomX Stock Discussion
$Damon Inc (DMN.US)$ Can be my PM gapper. Low float EV stock. IPO las...
📊⚡️📊
CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors
No comment yet